Years Ended December 31
2019
2018
Salaries, Wages and Benefits 
$8,471,278
$5,823,057
Professional Fees  
850,086
362,678
Acquisition Related Costs  
799,623
607,670
Board Compensation  
137,000
144,125
Investor Relations  
105,639
113,059
Consultants  
245,386
167,694
Advertising and Promotion  
709,006
299,955
Depreciation and Amortization  
1,282,786
316,502
Research, Development, and Maintenance  
2,672,406
675,660
Integration Incentives  
208,855
132,500
Office, Facility and Other  
695,493
472,250
Travel  
695,283
390,563
   Subtotal  
16,872,841
9,505,713
Stock-based Compensation  
2,260,298
2,520,852
Total Operating Expense 
$19,133,139
$12,026,565

text: Operating Expenses
text: Operating expenses increased to approximately $19.1 million for the year ended December 31, 2019, from approximately $12.0 million for the year ended December 31, 2018, an increase of approximately 60%. The detail by major category is reflected in the table below.
text: The main drivers for the overall increase in operating expenses in 2019 was our focus on staffing and scaling our company to foster, and be able to support, accelerated revenue growth.
text: Within the operating expenses, there were a variety of increases, the largest of which was in salaries, wages and benefits, as a result of additional staff added in 2018 and 2019, including related benefits. During 2019, we hired a chief commercial officer, a chief technology officer, five new salespeople, a human resources manager, as well as other administrative positions. We also added 14 employees as a result of our RMDY acquisition in October 2019. During 2018, we added to our staff in several key areas, including a head of data analytics, an additional VP of sales, and a controller. We also added 10 employees in late 2018 as a result of our CareSpeak acquisition. The full year impact of these 2018 hires also increased payroll expense in 2019. We expect our compensation expense to increase in 2020, but at a much lower rate than in 2019.
text: Professional fees increased primarily because of costs associated with our uplisting to Nasdaq and the completion of the underwritten offering, as well as ongoing compliance with Sarbanes Oxley. We also switched auditors in 2019, which resulted in higher audit fees.
text: Acquisition costs are related to our acquisitions of RMDY Health in 2019 and CareSpeak Communications in October 2018. These costs include investment banker fees, legal and accounting due diligence, audit costs associated with CareSpeak, valuation experts for the purchase price allocation, and other miscellaneous costs. Since RMDY Health was a larger company than CareSpeak Communications, the costs associated with the acquisition were higher.
text: Board compensation decreased slightly from 2018 to 2019 as we had five independent directors for a portion of 2018, as opposed to the four that we had in 2019.
text: The cost of consultants increased from 2018 to 2019. The primary reason for the increase was related to consultants used for quality certifications, as well as for marketing activities.
text: Our advertising and promotion costs increased significantly from 2018 to 2019 as a result of increased marketing activities. This included increased attendance and sponsorship at conferences, rebranding, and other marketing activities.
text: Expenses related to research, development, management, and maintenance of our technology increased in 2019 primarily as a result of research into potential new product areas.
text: Integration incentives, which are fees paid to accelerate access to new partners, increased in 2019, as we launched with a greater number of new EHRs in 2019 than in 2018.
text: Depreciation and amortization increased significantly in 2019 from the 2018 levels. The increased amortization resulting from the acquisition of CareSpeak and the resulting intangible assets were amortized for a full year in 2019 as opposed to only the fourth quarter of 2018. We also had three months of amortization related to the intangible assets acquired as part of the acquisition of RMDY in October 2019. We expect depreciation and amortization expense in 2020 to increase over 2019 levels due to the full year of amortization of RMDY intangibles.
text: Office, facility, and other costs increased from 2018 to 2019. The main reason for the change related to a higher level of activity with more employees and increased expenses resulting from the RMDY acquisition.
text: Stock based compensation decreased by approximately $260,000 from $2.5 million in 2018 to $2.3 million in 2019 primarily because performance-based awards granted in 2018 vested, whereas performance-based awards granted in 2019 did not vest because we did not meet the stretch goals required for vesting.

Questions:
question: What were the main drivers for the overall increase in operating expenses in 2019? 
answer: our focus on staffing and scaling our company to foster, and be able to support, accelerated revenue growth
question: What were the total operating expenses during fiscal years 2018 and 2019, respectively? 
answer: $12,026,565
$19,133,139
question: What is the percentage change in salaries, wages, and benefits expense in 2019 compared to 2018?
answer: 45.48
derivation: (8,471,278-5,823,057)/5,823,057 
scale: percent
question: What is the proportion of investor relations and consultants over the total operating expense in 2019?
answer: 0.02
derivation: (105,639+245,386)/19,133,139 
question: What is the ratio of integration incentives expense in 2019 to 2018?
answer: 1.58
derivation: 208,855/132,500 
question: Why did the board compensation decreased slightly from 2018 to 2019?
answer: we had five independent directors for a portion of 2018, as opposed to the four that we had in 2019